90 likes | 198 Views
Polymerase δ and ε in colon cancer. Aaron Stevens. Polymerase δ and ε contain both polymerase and exonuclease domains . Polymerase δ and ε are the major replicative polymerases. Pol δ and ε help repair damage. Mutating the exonuclease domain leads to decreased survival rates.
E N D
Polymerase δ and εin colon cancer Aaron Stevens
Polymerase δ and ε contain both polymerase and exonuclease domains
Mutating the exonuclease domain leads to decreased survival rates
Mutating the exonucleasedomain of Polymerase δleads to cancer
References • Biard Denis S.F. (2011). New Insight on Entangled DNA Repair Pathways: Stable Silenced Human Cells for Unraveling the DDR Jigsaw, DNA Repair - On the Pathways to Fixing DNA Damage and Errors, Dr. Francesca Storici (Ed.), ISBN: 978-953-307-649-2, InTech, DOI: 10.5772/23681. • Prindle, M. J. and Loeb, L. A. (2012), DNA polymerase delta in dna replication and genome maintenance. Environ. Mol. Mutagen., 53: 666–682. doi: 10.1002/em.21745 • Goldsby RE, Hays LE, Chen X, Olmsted EA, Slayton WB, Spangrude GJ, Preston BD. High incidence of epithelial cancers in mice deficient for DNA polymerase δ proofreading. PNAS.2002;99(24):15560–15565. doi: 10.1073/pnas.232340999. • Burgers P. M. (2009) Polymerase dynamics at the eukaryotic DNA replication fork. J. Biol. Chem. 284, 4041–4045 • Albertson T. M., Ogawa M., Bugni J. M., Hays L. E., Chen Y., Wang Y.,Treuting P. M., Heddle J. A., Goldsby R. E., Preston B. D. (2009) DNA polymerase ϵ and δ proofreading suppress discrete mutator and cancer phenotypes in mice.Proc. Natl. Acad. Sci. U.S.A. 106, 17101–17104 • Helmut Pospiech and Juhani E. Syväoja, “DNA Polymerase ε - More Than a Polymerase,”TheScientificWorldJOURNAL, vol. 3, pp. 87-104, 2003. doi:10.1100/tsw.2003.08 • Cancer Genome Atlas Network (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330–337 • Q. Zhou, R. Effati, K. Talvinen, H. Pospiech, J.E. Syväoja, Y. Collan. Genomic changes of the 55 kDa subunit of DNA polymerase epsilon in human breast cancer. Cancer Genomics Proteomics, 5 (2008), pp. 287–292